Table 1

Glypican-3 mRNA expression in patients with hepatocellular carcinoma

Patient No	Age (y)	Sex	Stage^1-a	Grade^1-b	Pushing/ invading^1-c	Relative optical density^1-d (northern blot analysis)
1	66	M	II	2	P	8.8
2	57	M	II	3	P	5.9
3	33	M	III	2	P	5.0
4	54	F	III	1	I	1.4
5	76	M	III	1	I	1.5
6	61	M	III	2	P	5.6
7	63	F	III	3	P	10.2
8	78	M	III	3	I	5.5
9	76	M	III	2	I	0.2
10	71	F	III	2	P	5.9
11	62	M	III	2	P	13.9
12	63	M	III	2	I	4.8
13	63	M	III	2	P	14.6
14	75	M	III	2	P	4.3
15	64	M	III	3	P	3.3
16	60	M	III	2	P	0.0
17	64	M	IV	3	P	0.3
18	54	M	IV	4	I	3.8
19	69	F	IV	2	I	0.0
20	66	M	IV	2	P	1.6
21	61	F	IV	3	P	1.5
22	65	M	IV	3	I	0.1
23	56	M	IV	3	I	10.1
24	73	M	IV	1	I	2.8
25	67	F	IV	3	P	17.5
26	68	M	IV	2	P	4.9
27	64	F	IV	2	I	1.9
28	38	F	IV	3	P	18.5
29	65	F	IV	3	P	20.5
30	52	F	IV	1	P	20.4

↵1-a No significant difference between stages III and IV (p>0.05);
↵1-b no significant difference between grades 1+2 and grades 3+4 (p>0.05);
↵1-c significant difference between pushing (P) and invading (I) groups (p<0.05);
↵1-d ratio of optical density of glypican-3/optical density of 7S.